BRCA1 and cancer: The indirect effects on the repair of single-strand breaks and of complex single strands through poly-ADP-ribose polymerase (PARP) are successfully exploited by the use of PARP-inhibitors in different BRCA1/2-mutated cancer entities [11,12].